ServiceNow Stock Just Got Slammed. Why I'm Still Not Buying the Dip.

ServiceNow’s Q1 subscription revenue rose 22% to $3.67 billion and total revenue increased 22% to $3.77 billion, while full-year subscription revenue guidance was raised to $15.735 billion-$15.775 billion. However, the stock fell nearly 17% as investors focused on a slower Q2 cRPO growth outlook of 19.5% constant currency, margin pressure from the Armis acquisition, and valuation near 50x earnings. The article argues the business remains strong but the shares still do not offer enough margin of safety amid AI-related software pricing concerns.

Analysis

The market is not really punishing a miss; it is repricing duration risk in high-multiple software. ServiceNow’s core growth is still good, but the stock’s premium leaves little room for even temporary evidence of deceleration, and that matters more when investors are questioning whether AI will compress software pricing power before it expands product value.

The more interesting second-order effect is competitive. A hybrid seat-plus-usage model is defensive today because it preserves monetization in an AI world, but it also normalizes usage-based pricing across enterprise software, which can pressure other workflow and ITSM vendors faster than it helps NOW. If customers increasingly buy tokens/connectors/infrastructure rather than named seats, the winners over the next 12-24 months are the platform vendors with the strongest attach rates and switching costs; the losers are point solutions that cannot prove consumption-linked ROI.

The near-term risk is not demand collapse, but multiple compression if management guides to even slightly softer cRPO momentum or if the market interprets acquisition-related margin drag as a signal that growth will be funded rather than self-funding. The Middle East delay looks transient, but the stock reaction suggests investors are using any operational noise as a reason to de-rate the group. That creates a setup where good news may need to be materially better than expected to re-rate the name.

The contrarian read is that the selloff may be more about factor exposure than fundamentals: once a category leader is seen as expensive, the market extrapolates AI disruption into every software model regardless of evidence. That could be overdone for NOW specifically because its platform breadth and pricing flexibility make it one of the better-positioned incumbents, but the valuation still offers poor asymmetry unless growth re-accelerates visibly over the next 1-2 quarters.

Key Decisions for Investors

• Avoid initiating new long NOW at current levels; wait for either a 10-15% further pullback or a quarter of re-acceleration in cRPO before stepping in. Risk/reward is unfavorable while the stock trades at ~50x earnings and the market is de-rating software multiples.
• For investors forced to own the group, rotate from NOW into lower-multiple enterprise software with clearer AI monetization and less margin drag over the next 12 months. The key is to own names where valuation does not require perfect execution.
• Use a call spread only after evidence that the usage-based pricing mix is translating into durable net-new ACV growth; otherwise the implied volatility in NOW likely overstates upside. Time horizon: next 1-2 earnings cycles.
• Pair trade: long a higher-quality enterprise software compounder with stronger free-cash-flow conversion, short NOW as a relative-value hedge against software multiple compression. This works best if AI fears keep pressuring premium SaaS names over the next 3-6 months.
• For traders already short, take partial profits on a 5-8% additional drawdown from here or on any confirmation that the delayed deals closed cleanly in Q2. The primary risk to the short is a fast sentiment snapback if management proves the margin drag is contained.